RNA Clinical Trials Solutions

  1. Early Phase Trials In Australia 9/6/2024

    Australia is a preferred destination for early phase trials because of simple and fast regulatory stream and lucrative R&D cash refund scheme.

  2. Comprehensive Data And Analytics For Cell, Gene, And RNA-Based Therapies 10/19/2022

    Stay on top of changes in the ever-evolving world of cell and gene therapies and more. Our in-house subject matter experts comb through the data weekly to ensure we provide you with the most current and comprehensive information important to this market.

  3. New Next-Generation GMP Facility 5/16/2023

    A new state-of-the-art GMP facility has been created to accelerate the development of CRISPR-based cell and gene therapies, overcoming challenges such as procuring reliable GMP-grade sgRNA persist.

  4. Propelling Your CGTx Innovation To The Next Stage 2/22/2023

    Discover how integrated end-to-end services can propel innovation to the next stage, from research and clinical development to manufacturing to commercialization.

  5. Trusted Partner For Clinical And Regulatory Success 12/2/2025

    Novotech’s Regulatory Affairs team offers customized, end-to-end clinical and regulatory solutions, guiding biotechnology, pharmaceutical, and medical device companies through the entire product lifecycle.

  6. Infectious Diseases And Vaccines CRO Services 6/27/2023

    Many biotechnology companies look at the Asia-Pacific region for their trials in Infectious diseases and Vaccines due to the high prevalence of diseases such as Hepatitis (Hepatitis B, Hepatitis C), HIV, and Influenza across the region.

  7. Patient Recruitment And Site Selection 12/20/2022

    Novotech relies on years of experience, in-country knowledge, and real-life big data to identify and propose the best-performing sites. Uncover the possibilities for your next study.